scieee Open visual document viewer

Inactivation of Sox9 in fibroblasts reduces cardiac fibrosis and inflammation

Scharf, Gesine M.,Kilian, Katja,Cordero, Julio,Wang, Yong,Grund, Andrea,Hofmann, Melanie,Froese, Natali,Wang, Xue,Kispert, Andreas,Kist, Ralf,Conway, Simon J.,Geffers, Robert,Wollert, Kai C.,Dobreva, Gergana,Bauersachs, Johann,Heineke, Joerg,Scharf, G.

Abstract

Fibrotic scarring drives the progression of heart failure after myocardial infarction (MI). Therefore, the development of specific treatment regimens to counteract fibrosis is of high clinical relevance. The transcription factor SOX9 functions as an important regulator during embryogenesis, but recent data point towards an additional causal role in organ fibrosis. We show here that SOX9 is upregulated in the scar after MI in mice. Fibroblast specific deletion of Sox9 ameliorated MI-induced left ventricular dysfunction, dilatation and myocardial scarring in vivo. Unexpectedly, deletion of Sox9 also potently eliminated persisting leukocyte infiltration of the scar in the chronic phase after MI. RNA-sequencing from the infarct scar revealed that Sox9 deletion in fibroblasts resulted in strongly downregulated expression of genes related to extracellular matrix, proteolysis and inflammation. Importantly, Sox9 deletion in isolated cardiac fibroblasts in vitro similarly affected gene expression as in the cardiac scar and reduced fibroblast proliferation, migration and contraction capacity. Together, our data demonstrate that fibroblast SOX9 functions as a master regulator of cardiac fibrosis and inflammation and might constitute a novel therapeutic target during MI.

Full text

Inac i a ion o Sox9 in ib oblas s educes ca diac ib osis and in lamma ion Gesine M. Scha , … , Johann Baue sachs, Joe g Heineke JCI Insigh . 2019;4(15):e126721. h ps://doi.o g/10.1172/jci.insigh .126721. Fib o ic sca ing d i es he p og ession o hea ailu e a e myoca dial in a c ion (MI). The e o e, he de elopmen o speci ic ea men egimens o coun e ac ib osis is o high clinical ele ance. The ansc ip ion ac o sex-de e mining egion Y box 9 (SOX9) unc ions as an impo an egula o du ing emb yogenesis, bu ecen da a poin owa d an addi ional causal ole in o gan ib osis. We show he e ha SOX9 is up egula ed in he sca a e MI in mice. Fib oblas -speci ic dele ion o Sox9 amelio a ed MI-induced le en icula dys unc ion, dila a ion, and myoca dial sca ing in i o. Unexpec edly, dele ion o Sox9 also po en ly elimina ed pe sis ing leukocy e in il a ion o he sca in he ch onic phase a e MI. RNA-Seq om he in a c sca e ealed ha Sox9 dele ion in ib oblas s esul ed in s ongly down egula ed exp ession o genes ela ed o ex acellula ma ix, p o eolysis, and in lamma ion. Impo an ly, Sox9 dele ion in isola ed ca diac ib oblas s in i o simila ly a ec ed gene exp ession as in he ca diac sca and educed ib oblas p oli e a ion, mig a ion, and con ac ion capaci y. Toge he , ou da a demons a e ha ib oblas SOX9 unc ions as a mas e egula o o ca diac ib osis and in lamma ion and migh cons i u e a no el he apeu ic a ge du ing MI. Resea ch A icle Ca diology Find he la es e sion: h p://jci.me/126721/pd 1insigh .jci.o g h ps://doi.o g/10.1172/jci.insigh .126721 RESEARCH ARTICLE Au ho ship no e: GMS and KK con ibu ed equally o his wo k. Con lic o in e es : The au ho s ha e decla ed ha no con lic o in e es exis s. Copy igh : © 2019, Ame ican Socie y o Clinical In es iga ion. Submi ed: Decembe 10, 2018 Accep ed: July 9, 2019 Published: July 16, 2019. Re e ence in o ma ion: JCI Insigh . 2019;4(15):e126721. h ps://doi.o g/10.1172/jci. insigh .126721. Inac i a ion o Sox9 in ib oblas s educes ca diac ib osis and in lamma ion Gesine M. Scha ,1,2 Ka ja Kilian,1 Julio Co de o,3 Yong Wang,1,4 And ea G und,1,2 Melanie Ho mann,1 Na ali F oese,1 Xue Wang,1 And eas Kispe ,5 Ral Kis ,6 Simon J. Conway,7 Robe Ge e s,8 Kai C. Wolle ,1,4 Ge gana Dob e a,3,9 Johann Baue sachs,1 and Joe g Heineke1,2,9 1Depa men o Ca diology and Angiology, Hanno e Medical School, Hanno e , Ge many. 2Depa men o Ca dio ascula Resea ch and 3Depa men o Ana omy and De elopmen al Biology Cen e o Biomedicine and Medical Technology Mannheim, Eu opean Cen e o Angioscience, Medical Facul y Mannheim o Heidelbe g Uni e si y, Mannheim, Ge many. 4Di ision o Molecula and T ansla ional Ca diology, Depa men o Ca diology and Angiology, and 5Ins i u e o Molecula Biology, Hanno e Medical School, Hanno e , Ge many. 6Ins i u e o Gene ic Medicine, Facul y o Medical Sciences, and Cen e o O al Heal h Resea ch, School o Den al Sciences, Newcas le Uni e si y, Newcas le upon Tyne, Uni ed Kingdom. 7HB Wells Cen e o Pedia ic Resea ch, Indiana Uni e si y School o Medicine, Indianapolis, Indiana, USA. 8Helmhol z Cen e o In ec ion Resea ch, B aunschweig, Ge many. 9Ge man Cen e o Ca dio ascula Resea ch pa ne si e Mannheim/Heidelbe g, Heidelbe g, Ge many. In oduc ion Ch onic hea ailu e (CHF) eme ges mos commonly a e myoca dial in a c ion (MI) in he Wes - e n wo ld (1). Despi e some ecen ad ances in ea men s a egies, he mo ali y o pa ien s wi h CHF emains unaccep ably high. Ca diac ib osis is a majo d i e o disease p og ession in CHF (2). Al hough he deposi ion o ex acellula ma ix (ECM) is needed o eplace dead ca diomyocy es a e MI and o p e en en icula up u e, excessi e ib osis causes la ge in a c sca s esul ing in ca diac dila a ion and educed ca diac unc ion (2–4). Wi hin he i s days a e MI, sca o ma ion coincides wi h he educ ion o leukocy e in il a ion and in lamma ion, which is ini ially needed o clea nec o ic ca diomyocy es (5). Adequa e e mina ion o he in lamma o y esponse, howe e , is equi ed in he myoca dium o p e en le en icula dila a ion, which (besides la ge MI size) is he main con ibu o o hea ailu e de elopmen and poo p ognosis (6). Al hough ini ial in a c size a e MI can be he apeu ically educed by immedia e pe cu aneous co ona y in e en ions o es o e pa ency o he in a c ed co ona y essel, ECM deposi ion and ela ed sca expansion as well as pe sis ing myoca dial in lamma ion canno be a ge ed by cu en he apies (6, 7). In his ega d, i would be especially desi able o modula e myoca dial sca issue in a way ha educes ma ix deposi ion and in lamma o y signals. Howe e , nei he he p edominan ly esponsible cell ype(s) no lineage- es ic ed nodal molecula egula o s ha could be add essed by u u e he apies a e well de ined. Fib o ic sca ing d i es he p og ession o hea ailu e a e myoca dial in a c ion (MI). The e o e, he de elopmen o speci ic ea men egimens o coun e ac ib osis is o high clinical ele ance. The ansc ip ion ac o sex-de e mining egion Y box 9 (SOX9) unc ions as an impo an egula o du ing emb yogenesis, bu ecen da a poin owa d an addi ional causal ole in o gan ib osis. We show he e ha SOX9 is up egula ed in he sca a e MI in mice. Fib oblas -speci ic dele ion o Sox9 amelio a ed MI-induced le en icula dys unc ion, dila a ion, and myoca dial sca ing in i o. Unexpec edly, dele ion o Sox9 also po en ly elimina ed pe sis ing leukocy e in il a ion o he sca in he ch onic phase a e MI. RNA-Seq om he in a c sca e ealed ha Sox9 dele ion in ib oblas s esul ed in s ongly down egula ed exp ession o genes ela ed o ex acellula ma ix, p o eolysis, and in lamma ion. Impo an ly, Sox9 dele ion in isola ed ca diac ib oblas s in i o simila ly a ec ed gene exp ession as in he ca diac sca and educed ib oblas p oli e a ion, mig a ion, and con ac ion capaci y. Toge he , ou da a demons a e ha ib oblas SOX9 unc ions as a mas e egula o o ca diac ib osis and in lamma ion and migh cons i u e a no el he apeu ic a ge du ing MI. 2 insigh .jci.o g h ps://doi.o g/10.1172/jci.insigh .126721 RESEARCH ARTICLE Residen ca diac ib oblas s a e conside ed he main homeos a ic p oduce o ECM in he hea , al hough o he cells, o example ca diomyocy es, a e also able o make and sec e e collagens (8). In esponse o pa hological o e load o ischemic inju y, quiescen ib oblas s become ac i a ed, p oli e a e, mig a e, and di e en ia e owa d a pa hological myo ib oblas pheno ype, which deposi s excess ECM and exe s con ac ile p ope ies (8). Sex-de e mining egion Y box 9 (SOX9) is a ansc ip ion ac o ha plays an essen ial ole du ing mammalian de elopmen , whe e i c ucially egula es chond ogenesis and sex di e en ia ion (9–12). He - e ozygous mu a ions o he SOX9 gene lead o he pheno ype o campomelic dysplasia, a human skele al mal o ma ion synd ome wi h XY sex e e sal ha is usually le hal wi hin he neona al pe iod (13, 14). As an impo an egula o o ECM genes, SOX9 plays a signi ican ole in he pa hogenesis o a ious ib o ic diseases, such as li e ib osis, glome uloscle osis, and hea al e calci ica ion (15–17). Recen ly, SOX9 was sugges ed o he i s ime as a po en ial egula o o ca diac ib osis in mice a e ischemia/ epe u- sion inju y (18). The unc ional ele ance o SOX9 in pa hological ca diac ib osis, he ca diac cell ype i ac s in o p omo e ECM deposi ion, as well as i s e ec on he en i e ib oblas ansc ip ome, howe e , emain cu en ly unknown. He e, we desc ibe ha ib oblas -speci ic down egula ion o Sox9 educes ECM deposi ion in a mouse model o MI in i o and ha i p e en s he ac i a ion owa d a p oli e a i e and mig a ing ib oblas pheno ype in cell cul u e in i o. In addi ion, we demons a e ha educed Sox9 exp ession in ib oblas s amelio a es pe sis ing in lamma ion wi hin he in a c sca , p e en s ca diac dila a ion, and imp o es ca diac unc ion a e MI. Resul s Sox9 is exp essed in ca diomyocy es and ca diac ib oblas s and is up egula ed a e MI in mice. Immuno luo escence s aining o SOX9, pla ele -de i ed g ow h ac o ecep o –α (PDGFR-α, a ma ke o ca diac ib oblas s) (19), and ca diac oponin T (as a ca diomyocy e ma ke ) showed exp ession o SOX9 in nuclei o ca diac ib oblas s and ca diomyocy es in adul mouse en icles (Figu e 1A). Quan i ica ion o mRNA le els in isola ed ca diomyocy es and isola ion o ca diac ib oblas s by quan i a i e PCR (qPCR) om uninju ed mouse hea s con i med Sox9 exp ession in bo h cell ypes, al hough mRNA le els o Sox9 we e ma ked- ly highe in ib oblas s compa ed wi h ca diomyocy es (Supplemen al Figu e 1A; supplemen al ma e ial a ailable online wi h his a icle; h ps://doi.o g/10.1172/jci.insigh .126721DS1). Analysis o SOX9 by immunoblo ing showed a signi ican up egula ion o SOX9 in he in a c zone ea ly a e MI (day 3), which pa ially dec eased o e ime in he sca egion 7 and 28 days a e MI bu emained signi ican ly ele a ed compa ed wi h uninju ed sham hea s o he emo e zone a e MI. In con as , en icula samples om he emo e a ea o he same MI-inju ed mice showed no signi ican di e ence in SOX9 p o ein le els compa ed o sham-ope a ed mice (Figu e 1, B–F). To in es iga e he unc ional ele ance o Sox9 in ac i a ed ib oblas s in i o, B6;129S -Sox9 m1Gs (Sox9 l/ l) mice we e b ed wi h mice exp essing C e ecombinase linked o he pe ios in (Pos n) p omo e o ob ain mice wi h speci ic Sox9 knockou in ac i a ed ib oblas s (Pos nC e/+ Sox9 l/ l; o sho , Sox9 l-Pe – C e; Figu e 2A). Pos n is exp essed in a ious s uc u es unde no mal condi ions du ing ca diac de el- opmen (e.g., in he de eloping ca diac cushions), bu i s exp ession in quiescen ib oblas s o ca diomy- ocy es o he uninju ed adul hea is negligible. Howe e , he Pos n-C e allele is obus ly up egula ed in adul ac i a ed ib oblas s ollowing ca diac inju y (20–24). Acco dingly, immuno luo escence s aining o SOX9 in he in a c a ea o Sox9 l-Pe –C e mice 7 days a e MI e ealed a ma ked educ ion o SOX9+ ib oblas s (s ained wi h PDGFR-α) compa ed wi h li e ma e con ols (Sox9 l/ l; o sho , Sox9 l/ l; see Figu e 2, B and C). Mo eo e , immunoblo analysis o Sox9 l-Pe –C e mice a e MI e ealed a ma ked educ ion o SOX9 p o ein le els compa ed wi h con ol mice only in he ca diac sca bu no in he emo e egion o he myoca dium (Figu e 2, D–F). Because he sca is composed mainly o ib oblas s wi h only a ew esidual myocy es, hese esul s sugges ed dec eased exp ession o SOX9 in ib oblas s wi hin he sca egion a e MI, bu no in he emo e a ea, which p edominan ly (a leas wi h ega d o cell olume) consis s o ca diomyocy es. Hence, Sox9 l-Pe –C e mice exe ed educed ib oblas SOX9 le els wi hin he sca bu no in he ca diomyocy e compa men in he emo e myoca dium. Fib oblas -speci ic Sox9 dele ion imp o es ca diac unc ion a e MI. To analyze he impac o ib oblas SOX9 a e MI, Sox9 l-Pe –C e and Sox9 l/ l (con ol mice) unde wen le an e io descending co ona y a e y (LAD) liga ion o sham su ge y. A e 42 days, we ound no di e ence in hea weigh /body 3 insigh .jci.o g h ps://doi.o g/10.1172/jci.insigh .126721 RESEARCH ARTICLE weigh (HW/BW) a io be ween Sox9 l-Pe –C e and con ol mice, while i signi ican ly inc eased in bo h geno ypes a e MI e sus sham-ope a ed mice (Figu e 3A). The lung weigh /body weigh (LW/BW) a io was no di e en be ween Sox9 l-Pe –C e and con ol mice, and he e was no di e ence be ween he MI and sham coho s, indica ing ha he animals we e in a compensa ed s a e o hea ailu e wi hou pulmona y edema (Figu e 3B). T ans ho acic echoca diog aphy e ealed a signi ican ly be e sys olic ca diac unc ion (measu ed as le en icula ejec ion ac ion) o he Sox9 l-Pe –C e compa ed wi h con ol mice 7 days a e MI, which was main ained un il 42 days a e su ge y (Figu e 3, C and D). Mo eo e , he le en icula chambe s o Sox9 l-Pe –C e mice we e signi ican ly less dila ed (i.e., exe ed a educed LVEDA) 7 and 42 days a e MI compa ed wi h con ol mice (Figu e 3, E and F). No di e ence occu ed be ween bo h geno ypes a any ime poin a e sham su ge y, and no ana omical abno mali ies we e obse ed in Sox9 l-Pe –C e mice. Dele ion o Sox9 in ib oblas s in i o educes myoca dial sca ing and ib oblas p oli e a ion a e MI. To iden i y he unde lying cause o he p ese a ion o ca diac unc ion a e MI upon Sox9 dele ion in ib oblas s, we quan i ied he ex en o myoca dial sca o ma ion in hea s 7 days a e MI. Masson’s ich ome s aining e ealed signi ican ly smalle myoca dial sca a eas in Sox9 l-Pe –C e compa ed wi h con ol mice (Figu e 4, A and B). Immuno luo escence s aining o he p oli e a ion ma ke Ki67 wi h PDGFR-α as a ib oblas ma ke sugges ed educed ib oblas p oli e a ion in he sca s o Sox9 l-Pe –C e compa ed wi h con ol mice 7 days a e MI (Figu e 4, C and D). To in es iga e whe he Figu e 1. Ca diac SOX9 p o ein le el a e MI. Adul wild- ype mice unde wen MI by pe manen liga ion o he le an e io descending a e y. (A) Rep e- sen a i e immuno luo escence images show SOX9 (g een) in ca diac ib oblas s (s ained wi h PDGFR-α, ed) and ca diomyocy es (s ained wi h oponin T, ed) in he emo e a ea; nuclei a e s ained wi h DAPI (blue). A ows indica e SOX9+ ca diac ib oblas s; a owheads indica e SOX9+ ca diomyocy es. Scale ba : 50 μm. (B–F) Wes e n blo analysis (B) and densi ome ic quan i ica ion (C–F) o SOX9 p o ein le el in hea issue o he emo e o in a c a ea and sham con ols isola ed om wild- ype mice 3, 7, o 28 days a e sham ope a ion o MI. Ponceau S ( ange 40–55 kDa) was used as a loading con ol. Fo compa ison o SOX9 p o ein le el in he in a c a ea a di e en ime poin s (F), da a we e no malized o 3-day sham as a e e ence. Da a a e shown as mean ± SEM. n = 3–4 mice/g oup; 1-way ANOVA wi h Tukey’s mul iple-compa isons es ; *P < 0.05, ***P < 0.001, ****P < 0.0001. 4 insigh .jci.o g h ps://doi.o g/10.1172/jci.insigh .126721 RESEARCH ARTICLE Sox9 dele ion p e en s he o ma ion o myo ib oblas s, we pe o med immuno luo escence s aining o smoo h muscle ac in (α-SMA) in in a c hea s o Sox9 l-Pe –C e compa ed wi h con ol mice. We ound a clea inc ease o α-SMA deposi ion in he in a c a ea o Sox9 l-Pe –C e mice as well as li e - ma e con ols compa ed wi h he emo e zone, wi h a end owa d highe α-SMA deposi ion in he in a c a ea o con ol mice, al hough a high a iabili y o s aining in ensi y exis ed wi hin he sca s and be ween mice (Figu e 4E). Quan i ica ion o Ac a2 mRNA le el in he emo e and in a c a ea o Sox9 l-Pe –C e and con ol mice 7 days a e MI con i med he inc ease o Ac a2 in he in a c a ea com- pa ed wi h con ol. Al hough he e was a end owa d lowe Ac a2 mRNA le el in he in a c issue o Sox9 l-Pe –C e compa ed wi h con ol mice, we did no ind a signi ican educ ion o Ac a2 mRNA le els upon Sox9 dele ion in ou in i o model (Figu e 4F). Dele ion o Sox9 in i o educes p oli e a ion, mig a ion, and gel con ac ion o ca diac ib oblas s bu has no di ec e ec on α-SMA o ma ion. To in es iga e he di ec e ec s o Sox9 dele ion on he pheno ype o ca diac ib oblas s, we ex ac ed ib oblas s om hea s o adul Sox9 l/ l mice and ea ed hem wi h adeno i uses exp essing C e ecombinase (AdC e) o con ol i us (Adβ-gal). qPCR and Wes e n blo - ing e ealed highly e icien down egula ion o Sox9 mRNA (by abou 90%) and p o ein exp ession (by abou 60%) in AdC e- ea ed ib oblas s in i o (Supplemen al Figu e 1B and Figu e 5, A and B). Cell p oli e a ion was assessed wi h a B dU inco po a ion immunoassay, which e ealed signi ican ly less p oli e a ion in Sox9-de icien ib oblas s compa ed wi h con ol cells (Figu e 5C), he eby con i ming he in i o esul s shown in Figu e 4, C and D. To measu e he ib oblas con ac ile capaci y, which is a hallma k o cell di e en ia ion in o myo ib oblas s, he cells we e in ec ed wi h AdC e o Adβ-gal and Figu e 2. Fib oblas -speci ic Sox9 dele ion in i o. (A) Schema ic illus a ion showing he in e b eeding o B6;129S -Sox9 m1Gs (Sox9 l/ l) wi h Tg(Pos n-C e)1Sjc (Pe -C e) mice o ob ain mice wi h speci ic Sox9 dele ion in ac i a ed ca diac ib oblas s (Sox9 l-Pe –C e). (B and C) Rep esen a i e IHC images (B) and quan i ica ion (C) o SOX9+ ib oblas s om he sca a ea o Sox9 l/ l and Sox9 l-Pe –C e hea issue 7 days a e MI by pe manen liga ion o he le an e io descending a e y showing SOX9 (g een) in ca diac ib oblas s (s ained o PDGFR-α, ed); nuclei a e s ained wi h DAPI (blue). Scale ba s: 50 μm. A o al o n = 6 hea s pe g oup we e s ained, and a leas 4 images pe hea we e analyzed o C. (D–F) Wes e n blo analysis (D) and den- si ome ic quan i ica ion (E and F) illus a ing a highly e icien dele ion o SOX9 p o ein om Sox9 l-Pe –C e mouse ca diac sca issue 42 days a e MI. SOX9 p o ein le els in emo e samples a e MI show no signi ican di e ences. GAPDH was used as a loading con ol. Da a a e shown as mean ± SEM. n = 3 mice/g oup. Two- ailed S uden ’s es was used o compa ison o 2 g oups; *P < 0.05, **P < 0.01. 5 insigh .jci.o g h ps://doi.o g/10.1172/jci.insigh .126721 RESEARCH ARTICLE pou ed in o a collagen gel ma ix. A e 48 hou s, con ac ion was quan i ied as he di e ence be ween he gel a ea a e 48 hou s and 0 hou s, which showed ha gel ma ices wi h Sox9-de icien ib oblas s we e signi ican ly less con ac ed (indica ing less myo ib oblas abundance) han he con ol samples (Figu e 5D). Mo eo e , cell mig a ion was analyzed unde baseline condi ions o a e s imula ion wi h angio ensin II, TGF-β1, o FBS. The mig a ion le el, quan i ied as closu e o a de ined sc a ch a ea wi h- in 24 hou s, was educed in Sox9-de icien ca diac ib oblas s unde baseline condi ions as well as a e s imula ion wi h angio ensin II, TGF-β1, o FBS (Figu e 5, E–H). O e all, we ound ha Sox9 de iciency causes less ac i e ca diac ib oblas s compa ed wi h con ol cells in i o. Nex , we analyzed he o ma ion o s ess ibe s as a key ma ke o myo ib oblas di e en ia ion in iso- la ed ca diac ib oblas s wi h Sox9 dele ion compa ed wi h con ol cells, unde baseline condi ions o a e s imula ion wi h TGF-β1 o 24 hou s o induce myo ib oblas di e en ia ion. Unexpec edly, luo escence s aining o ilamen ous ac in wi h phalloidin and consecu i e quan i ica ion o s ess ibe –posi i e ib o- blas s ailed o e eal di e ences be ween Sox9-de icien ca diac ib oblas s and con ol cells (Supplemen al Figu e 1, C and D). Mo eo e , mRNA le els o key myo ib oblas di e en ia ion ma ke s, pa icula ly Ac a2 and o he s (Fmn1, Cnn1, Tagln), we e simila ly exp essed be ween Sox9-de icien ca diac ib oblas s and con ol cells (Supplemen al Figu e 1, E–H). Fib oblas SOX9 con ols ECM o ma ion and in lamma ion in he ch onic s age a e MI in i o. Nex , we in es- iga ed he e ec o ib oblas -speci ic Sox9 dele ion in he la e phase a e MI when he o ma ion o he ch onic sca is comple ed and myo ib oblas s a e u he di e en ia ed in o quiescen ma i ib ocy es (25). Figu e 3. Imp o ed ca diac unc ion o mice wi h ib oblas -speci ic Sox9 dele ion a e MI. Mo phological analysis and unc ional e alua ion o Sox9 l/ l and Sox9 l-Pe –C e mice 7 days and 42 days a e MI by pe manen liga ion o he le an e io descending a e y. (A and B) Quan i ica ion o he HW/BW a io (A) shows an inc ease in Sox9 l/ l and Sox9 l-Pe –C e mice 42 days a e MI; he LW/BW a io (B) shows no signi ican di e ences. (C–F) Echoca diog aphy showed an imp o ed ejec ion ac ion in Sox9 l-Pe –C e mice compa ed wi h Sox9 l/ l mice 7 (C) and 42 (D) days a e MI. Mo eo e , Sox9 l-Pe –C e mice exe ed less le en icula dila a ion, i.e., inc eased le en icula end-dias olic a ea (LVEDA), in ela ion o Sox9 l/ l mice 7 (E) and 42 (F) days a e MI. Sham-ope a ed mice had no impai men o ca diac unc ion. Da a show mean ± SEM. n = 4 (Sox9 l/ l and Sox9 l-Pe –C e; sham), n = 7 (Sox9 l/ l; MI), and n = 11 (Sox9 l-Pe – C e; MI). Two-way ANOVA wi h Holm-Šídák’s mul iple-compa isons es ; *P < 0.05, **P < 0.01, ***P < 0.001. 6 insigh .jci.o g h ps://doi.o g/10.1172/jci.insigh .126721 RESEARCH ARTICLE Masson’s ich ome s aining o he in a c ed hea s 42 days a e MI e ealed ha he sca a ea o Sox9 l- Pe –C e mice was s ill signi ican ly smalle compa ed wi h con ols a his la e s age (Figu e 6, A and B). To iden i y SOX9-dependen gene egula ion in he ch onic myoca dial sca , we pe o med a genome-wide ansc ip omic analysis o ca diac sca issue om Sox9 l-Pe –C e and Sox9 l/ l mice 42 days a e MI by RNA-Seq. Genes wi h signi ican di e en ial egula ion be ween bo h condi ions (a leas 50% up- o down egula ed) a e demons a ed in he hea map (Figu e 6C and Supplemen al Figu e 2A). In he ch onic in a c sca o Sox9 l-Pe –C e mice, 2611 genes we e down egula ed and belonged o he GO (biological p ocess) classes ca ilage de elopmen , cell chemo axis, ex acellula ma ix o ganiza ion, immune esponse, and p o eolysis (Figu e 6C). Highly down egula ed genes in he myoca dial sca o Sox9 l-Pe –C e mice included mainly collagen genes (Col2a1, Col9a2, Col11a1), in lamma o y media o s (Cxcl13, Il6, Tn s 15), and p o eases (Adam32, P ss23, Capn6; o he example genes a e lis ed in Figu e 6C and in Supplemen al Figu e 2, B–D). In he sca o Sox9 l-Pe –C e mice, 1218 genes we e up egula ed, which we e ela ed mainly o oxida i e cellula me abolism (GO classes ATP me abolic p ocess, ica boxylic acid cycle, and a y acid me abolic p ocess), o example, A p5b, Idh3a, and Acadl, bu we also ound genes o he ca ego y muscle con ac ion, o example, Myh6, Tnni3, and T n (mo e example genes a e lis ed in Figu e 6C) wi hin his g oup. We subsequen ly Figu e 4. Fib oblas -speci ic Sox9 dele ion educes he sca a ea and a enua es he ac i a ion o ca diac ib oblas s a e MI. (A and B) Masson’s ich ome s aining o ep esen a i e mid en icula sec ions (A) and quan i ica ion o he sca a ea (B) o Sox9 l-Pe –C e (n = 9) compa ed wi h Sox9 l/ l (n = 7) mouse hea s 7 days a e MI. Scale ba s: 1 mm. (C and D) Rep esen a i e IHC images showing Ki67 (g een) and PDGFR-α ( ed) as ma ke s o ib oblas p oli e a ion in he in a c egion o Sox9 l/ l and Sox9 l-Pe –C e mouse hea s 7 days a e MI (C) and quan i ica ion (D). Nuclei a e shown wi h DAPI (blue). A ows indica e exempla y Ki67+ ib oblas s. Scale ba s: 100 μm. A o al o 5 hea s pe g oup we e s ained, and 4 images pe hea we e analyzed o D. (E) Rep esen a i e IHC images showing SOX9 (g een) and α-SMA ( ed) in he emo e and in a c a ea o Sox9 l/ l and Sox9 l-Pe –C e mouse hea s 7 days a e MI. Nuclei a e shown wi h DAPI (blue). Rep esen a i e images o 5 hea s pe g oup a e shown. Scale ba s: 100 μm. (F) mRNA exp ession o Ac a2 measu ed wi h e e se ansc ip ion PCR in samples o he emo e and in a c a ea o Sox9 l/ l and Sox9 l-Pe –C e mouse hea s 7 days a e MI. Da a we e no malized o Ac a2 in he emo e a ea o Sox9 l/ l mice 7 days a e MI. n = 5 (Sox9 l/ l) and 6 (Sox9 l-Pe –C e). Da a a e shown as mean ± SEM. S uden ’s es was used o compa ison o 2 g oups (B and D); 2-way ANOVA wi h Holm-Šídák’s mul iple-compa isons es was used o F. P alue o Ac a2 in he in a c a ea o Sox9 l/ l and Sox9 l-Pe –C e was 0.11 (indica ed as n.s. in F). **P < 0.01, ****P < 0.0001. 7 insigh .jci.o g h ps://doi.o g/10.1172/jci.insigh .126721 RESEARCH ARTICLE ocused on he genes ha we e down egula ed because o Sox9 dele ion in Sox9 l-Pe –C e mice because o hese genes di ec egula ion by SOX9 was mo e likely. To in es iga e whe he hese down egu- la ed genes migh be di ec a ge s o SOX9, we in e sec ed ou RNA-Seq da a wi h SOX9 ChIP-Seq esul s om de eloping mammalian chond ocy es (26). In ha s udy, SOX9 binding egions we e cha ac e ized h oughou he genome, and SOX9 was ound o bind close o he p omo e in an indi- ec manne (“class I engagemen ,” ound mos ly in genes wi h gene al cellula unc ions) o o bind di ec ly o DNA in enhance egions o ca ilage- ela ed genes, which we e in la ge pa iden ical o he ECM genes in ou s udy. In e sec ion wi h he down egula ed genes om ou da a se e ealed ha 50.5% o he down egula ed genes exe ed di ec SOX9 binding, whe eby 43% showed class II engage- men o bo h class I and class II engagemen . GO e m analysis in hese 43% o down egula ed genes e lec ed e y simila GO classes (leukocy e mig a ion, cell chemo axis, ex acellula ma ix o gani- za ion; Supplemen al Figu e 3A) as obse ed among all down egula ed genes in he myoca dial sca o Sox9 l-Pe –C e mice. KEGG pa hway analysis e ealed sligh ly mo e class I engagemen alone bu Figu e 5. In i o Sox9 dele ion in ca diac ib oblas s educes mig a ion, p oli e a ion, and con ac ili y. Isola ed ca diac ib oblas s om uninju ed Sox9 l/ l mouse hea s we e in ec ed wi h adeno i us exp essing C e ecombinase (AdC e) o gene a e in i o Sox9 loss o unc ion o con ol adeno i- us (Adβ-gal). (A and B) E iciency o SOX9 dele ion is demons a ed on he p o ein le el by Wes e n blo (A) and densi ome ic quan i ica ion (B). (C) P oli e a ion o ca diac ib oblas s wi h Sox9 dele ion compa ed wi h con ol cells was measu ed by B dU inco po a ion (n = 24 samples/g oup). (D) Con- ac ion capaci y o ca diac ib oblas s quan i ied as a ea change o a collagen ma ix con aining ib oblas s wi h Sox9 dele ion o con ol cells a e 48 hou s compa ed wi h baseline a 0 (n = 6 samples/g oup). (E–H) Mig a ion o Sox9 l/ l ib oblas s ea ed wi h ei he Adβ-gal (β-gal) o AdC e (C e) unde baseline condi ions (uns imula ed, E) o in he p esence o p o ib o ic s imuli angio ensin II (Ang II, F), TGF-β1 (G), o 10% FBS (H), quan i ied as sc a ch closu e a e 24 hou s. Rep esen a i e pic u es a e shown di ec ly a e sc a ch and 24 hou s la e ; n = 12 samples/g oup. Scale ba s: 400 μm. Da a a e shown as mean ± SEM. Two- ailed S uden ’s es was used o compa ison o 2 g oups; **P < 0.01; ***P < 0.001. 8 insigh .jci.o g h ps://doi.o g/10.1172/jci.insigh .126721 RESEARCH ARTICLE iden i ied o he wise simila unc ional classes (cy okine-cy okine ecep o in e ac ion, ECM- ecep o in e ac ion, p o ein diges ion and abso p ion; Supplemen al Figu e 3B). Supplemen al Figu e 4 shows exempla y esul s o class I and class II binding o SOX9 o selec ed ECM genes (Col2a1, Col9a2, and Fn1; Supplemen al Figu e 4, A–C), in lamma o y genes (Cxcl13 and Il6; Supplemen al Figu e 4; D and E), and a p o eolysis gene (Mmp2; Supplemen al Figu e 4F) in conjunc ion wi h ou RNA-Seq esul s. These da a imply a di ec in e ac ion o SOX9 wi h he p omo e o enhance egions o ECM, p o e- olysis, o in lamma o y genes iden i ied in his s udy. Because RNA-Seq showed dec eased exp ession o in lamma o y media o s in he sca egion o Sox- 9 l-Pe –C e mice, we in es iga ed leukocy e abundance 6 weeks a e MI, which was s ongly diminished upon educed ib oblas SOX9 le els bo h in he sca as well as in he emo e a ea, al hough in he sca leukocy e abundance was gene ally highe in bo h con ol and Sox9 l-Pe –C e mice (Figu e 7, A and B). As one example o he ECM- ela ed gene exp ession, we con i med educed COL2A1 p o ein abundance in he sca o Sox9 l-Pe –C e mice by Wes e n blo and immuno luo escence s aining (Figu e 7, C–E). Figu e 6. Fib oblas -speci ic Sox9 dele ion educes he sca a ea and inhibi s exp ession o p oin lamma o y and ECM genes a e long- e m MI. (A and B) Masson’s ich ome s aining o ep esen a i e mid en icula sec ions (A) and quan i ica ion o he sca a ea (B) (n = 6–11) o Sox9 l-Pe –C e compa ed wi h Sox9 l/ l mouse hea s 42 days a e MI. Scale ba s: 1 mm. (C) Gene exp ession in sca a ea issue o Sox9 l-Pe –C e compa ed wi h Sox9 l/ l mouse hea s 42 days a e MI was analyzed wi h RNA-Seq. Hea map o di e en ially egula ed genes in he MI sca o Sox9 l/ l and Sox9 l-Pe –C e mice (n = 3) 42 days a e MI is shown on he le o C. Gene On ology (GO, biological p ocess) classi ica- ion o highly egula ed p ocesses and selec ed example genes a e demons a ed on he igh . Bioin o ma ic analysis o RNA-Seq da a is desc ibed in he Me hods sec ion. Da a a e shown as mean ± SEM. S uden ’s es was used o compa ison o 2 g oups; *P < 0.05. 15 insigh .jci.o g h ps://doi.o g/10.1172/jci.insigh .126721 RESEARCH ARTICLE 26. Ohba S, He X, Hojo H, McMahon AP. Dis inc ansc ip ional p og ams unde lie Sox9 egula ion o he mammalian chond ocy e. Cell Rep. 2015;12(2):229–243. 27. F angogiannis NG. The mechanis ic basis o in a c healing. An ioxid Redox Signal. 2006;8(11–12):1907–1939. 28. Shinde AV, F angogiannis NG. Fib oblas s in myoca dial in a c ion: a ole in in lamma ion and epai . J Mol Cell Ca diol. 2014;70:74–82. 29. Lindne D, e al. Ca diac ib oblas s suppo ca diac in lamma ion in hea ailu e. Basic Res Ca diol. 2014;109(5):428. 30. Sa o Y, Yanagi a M. Residen ib oblas s in he kidney: a majo d i e o ib osis and in lamma ion. In lamm Regen. 2017;37:17. 31. Kanisicak O, e al. Gene ic lineage acing de ines myo ib oblas o igin and unc ion in he inju ed hea . Na Commun. 2016;7:12260. 32. Kamachi Y, Kondoh H. Sox p o eins: egula o s o cell a e speci ica ion and di e en ia ion. De elopmen . 2013;140(20):4129–4144. 33. P i che J, A hwal V, Robe s N, Hanley NA, Hanley KP. Unde s anding he ole o SOX9 in acqui ed diseases: lessons om de elopmen . T ends Mol Med. 2011;17(3):166–174. 34. Fu ado MB, e al. Ca diogenic genes exp essed in ca diac ib oblas s con ibu e o hea de elopmen and epai . Ci c Res. 2014;114(9):1422–1434. 35. C eeme s EE, Cleu jens JP, Smi s JF, Daemen MJ. Ma ix me allop o einase inhibi ion a e myoca dial in a c ion: a new app oach o p e en hea ailu e? Ci c Res. 2001;89(3):201–210. 36. Fon ana L, e al. Fib onec in is equi ed o in eg in α β6-media ed ac i a ion o la en TGF-β complexes con aining LTBP-1. FASEB J. 2005;19(13):1798–1808. 37. Ge G, G eenspan DS. BMP1 con ols TGFβ1 ac i a ion ia clea age o la en TGFβ-binding p o ein. J Cell Biol. 2006;175(1):111–120. 38. Ammi an e M, Shalapou S, Kang Y, Jamieson CA, Ka in M. Tissue inju y and hypoxia p omo e malignan p og ession o p os a e cance by inducing CXCL13 exp ession in umo myo ib oblas s. P oc Na l Acad Sci U S A. 2014;111(41):14776–14781. 39. Kis R, Sch ewe H, Balling R, Sche e G. Condi ional inac i a ion o Sox9: a mouse model o campomelic dysplasia. Genesis. 2002;32(2):121–123. 40. Lindsley A, e al. Iden i ica ion and cha ac e iza ion o a no el Schwann and ou low ac endoca dial cushion lineage- es ic - ed pe ios in enhance . De Biol. 2007;307(2):340–355. 41. F oese N, e al. An i-and ogenic he apy wi h inas e ide imp o es ca diac unc ion, a enua es emodeling and e e s pa holog- ic gene-exp ession a e myoca dial in a c ion in mice. J Mol Cell Ca diol. 2018;122:114–124. 42. Heinz S, e al. Simple combina ions o lineage-de e mining ansc ip ion ac o s p ime cis- egula o y elemen s equi ed o mac- ophage and B cell iden i ies. Mol Cell. 2010;38(4):576–589. 43. Ta azona S, Fu ió-Ta í P, Tu à D, Pie o AD, Nueda MJ, Fe e A, Conesa A. Da a quali y awa e analysis o di e en ial exp ession in RNA-seq wi h NOISeq R/Bioc package. Nucleic Acids Res. 2015;43(21):e140. 44. Ramí ez F, Dünda F, Diehl S, G üning BA, Manke T. deepTools: a lexible pla o m o explo ing deep-sequencing da a. Nucleic Acids Res. 2014;42(Web Se e issue):W187–W191.. 45. Appa i M, e al. C1q-TNF- ela ed p o ein-9 p omo es ca diac hype ophy and ailu e. Ci c Res. 2017;120(1):66–77. 46. Da is J, Bu AR, Da is GF, Bi nbaume L, Molken in JD. A TRPC6-dependen pa hway o myo ib oblas ansdi e en ia ion and wound healing in i o. De Cell. 2012;23(4):705–715.